The impact of birth control pills on oral health can present with varying, at times conflicting, responses. However, in light of the FDA’s recent sanctioning of the first over-the-counter oral contraceptive, this subject warrants thoughtful consideration.
The FDA’s recent approval of the first over-the-counter oral contraceptive, Opill, has raised discussions within the dental community regarding the potential impact of contraceptive use on oral health.
Key Points:
- The FDA has approved Opill, the first OTC daily oral contraceptive without prescription in the US, expected to hit the market in 2024.
- High levels of ovarian hormones from pregnancy or oral contraceptive use can exacerbate gingival inflammation and bacterial growth, altering oral conditions.
- Contraceptive use, unlike pregnancy, can span years or decades, making its impact on oral health more long-term.
- Research on the impact of contraceptives on oral health is limited and inconclusive, but links to periodontal diseases, decreased bone mineral density, dry socket, and temporomandibular disorders (TMDs) have been suggested.
Additional Points:
- Early contraceptive formulations had high hormone doses compared to current versions, leading some researchers to question the validity of previous studies’ findings.
- Some recent studies suggest that oral contraceptives may no longer pose an increased risk for gingivitis or periodontitis.
- The Cleveland Clinic points out that hormonal changes during certain stages of a woman’s life can make them more susceptible to oral health problems.
- Other oral disorders, like TMJ, are linked to decreased natural estrogen levels, which can be influenced by synthetic estrogens in birth control pills. However, the FDA-approved Opill does not contain estrogen.
- Antibiotics and certain other medications prescribed by dentists can potentially lower oral contraceptives’ effectiveness.
Conclusion:
- Dental professionals need to be aware of the potential impacts of long-term oral contraceptive use on patients’ oral health, as well as possible drug interactions, despite inconclusive research findings.
OBGYN Latest Posts
- Prenatal cfDNA Sequencing and Incidental Detection of Maternal Cancer
- New UTI Guidelines Reveal Major Evidence Gaps
- Use of Progestogens and the Risk of Intracranial Meningioma: National Case-control Study
- Randomized Trial of Very Early Medication Abortion
Did You Know?
Studies suggest that oral contraceptive pills have been associated with a 50% reduction in the risk of ovarian cancer.